Patents by Inventor Alexis Guy Andre Lucien Parisot

Alexis Guy Andre Lucien Parisot has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunogenic formulations comprising linear or branched polyacrylic acid polymer adjuvants
    Patent number: 11554170
    Abstract: The present invention provides for novel immunological and vaccine formulations comprising a newly applied non-crosslinked polyacrylic acid polymer adjuvant. The adjuvants may be combined with a wide variety of immunogens to produce vaccines that are safe and effective when administered to a wide range of target animals. The immunogens may include, but are not limited to: inactivated pathogens, attenuated pathogens, subunits, recombinant expression vectors, plasmids or combinations thereof. The animals may include, but are not limited to: humans, murine, canines, felines, equines, porcines, ovines, caprines and bovines.
    Type: Grant
    Filed: June 15, 2017
    Date of Patent: January 17, 2023
    Assignees: Sanofi Pasteur SA, Boehringer Ingelheim Animal Health USA Inc.
    Inventors: Guillaume Rigaut, Alexis Guy André Lucien Parisot, Karelle De Luca, Christine Michele Pierrette Andreoni, Lydie Remolue, Marie Garinot, Jean-François Cotte, Patricia Probeck-Quellec, Jean Haensler, Véronique Chambon, Philippe Talaga
  • Multi-dose compositions containing an antimicrobial polyamide or octenidine preservative
    Patent number: 10583154
    Abstract: The present invention relates to non-mercurial preservatives, including antimicrobial polyamide polymers and octenidine, and to methods of use thereof to produce preservative-containing multi-dose formulations. The preservative-containing multi-dose formulations exhibit resistance to one or more contaminating microorganisms, and have advantageous properties with respect to long term stability of biological and small molecule active ingredients.
    Type: Grant
    Filed: April 13, 2017
    Date of Patent: March 10, 2020
    Assignees: Boehringer Ingelheim Animal Health USA Inc., GENZYME CORPORATION
    Inventors: Guillaume Rigaut, Celine Loss-Dunod, Alexis Guy Andre Lucien Parisot, Pradeep K. Dhal
  • Novel immunogenic formulations comprising linear or branched polyacrylic acid polymer adjuvants
    Publication number: 20170360923
    Abstract: The present invention provides for novel immunological and vaccine formulations comprising a newly applied non-crosslinked polyacrylic acid polymer adjuvant. The adjuvants may be combined with a wide variety of immunogens to produce vaccines that are safe and effective when administered to a wide range of target animals. The immunogens may include, but are not limited to: inactivated pathogens, attenuated pathogens, subunits, recombinant expression vectors, plasmids or combinations thereof. The animals may include, but are not limited to: humans, murine, canines, felines, equines, porcines, ovines, caprines and bovines.
    Type: Application
    Filed: June 15, 2017
    Publication date: December 21, 2017
    Applicants: MERIAL INC., Sanofi Pasteur
    Inventors: Guillaume Rigaut, Alexis Guy André Lucien Parisot, Karelle De Luca, Christine Michele Pierrette Andreoni, Lydie Remolue, Marie Garinot, Jean-François Cotte, Patricia Probeck-Quellec, Jean Haensler, Véronique Chambon, Philippe Talaga
  • Multi-dose Compositions Containing an Antimicrobial Polyamide or Octenidine Preservative
    Publication number: 20170296577
    Abstract: The present invention relates to non-mercurial preservatives, including antimicrobial polyamide polymers and octenidine, and to methods of use thereof to produce preservative-containing multi-dose formulations. The preservative-containing multi-dose formulations exhibit resistance to one or more contaminating microorganisms, and have advantageous properties with respect to long term stability of biological and small molecule active ingredients.
    Type: Application
    Filed: April 13, 2017
    Publication date: October 19, 2017
    Applicants: MERIAL INC., GENZYME CORPORATION
    Inventors: Guillaume Rigaut, Celine Loss-Dunod, Alexis Guy Andre Lucien Parisot, Pradeep K. Dahl